WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1'0801 Infant (under 12 months) mortality rate: 332
GDP / capita (US$): 3'1361 Child (under 5 years) mortality rate: 412

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 158'513  156'595  154'695  152'862  151'125  132'383  107'386  82'498 
Births 3'122  3'138  3'150  3'161  3'174  3'576  3'768  3'560 
Surviving infants 3'030  3'039  3'045  3'049  3'055  3'353  3'406  3'098 
Pop. less than 5 years 15'190  15'128  15'074  15'118  15'309  16'731  16'553  14'325 
Pop. less than 15 years 46'743  46'977  47'197  47'475  47'852  48'951  45'160  36'594 
Female 15-49 years 44'559  43'874  43'170  42'427  41'634  32'645  24'027  17'546 

Number of reported case

(Click for retrospective incidence data for Bangladesh)
Diphtheria 13  16  11  27  21  711  1'559 
Japanese encephalitis 183  23  52  103  15 
Measles 289  237  1'986  5'625  788  5'098  1'705  11'077 
Mumps
Pertussis 12  13  44  17  252  4'879  12'436 
Polio* 198  374  65 
Rubella 381  3'034  3'245  5'631  12'963 
Rubella (CRS) 66  19 
Tetanus (neonatal) 108  109  98  117  376  740  1'068 
Tetanus (total)** 508  614  644  710  1'155  2'511  2'855 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Bangladesh)
Vaccine year result method % card seen                                                
BCG 2012  99  EPI   81  99  99  99  99  99  95  91 
DTP1 2012  99  EPI   81  93  91  99  99  99  88 
DTP3 2012  97  EPI   81  93  92  90  90  89  68  69 
DTP4         
IPV1         
HepB_BD         
HepB3 2012  97  EPI   81  93  92  90  90  89 
Hib3 2012  97  EPI   81  93  92  90  90  95 
JapEnc         
MCV1          90  89  89  86  89  61  82 
MCV2          70  99  22 
PCV1         
PCV3         
Pol3 2012  97  EPI   81  93  92  95  95  94  68  69 
Rota1         
Rota_last         
Rubella1          90  89  17 
TT2plus 2010  42  DHS   67  98  96  96  96  95  89  73 
PAB         
VAD1          85  84  92  85  93  68 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Bangladesh)
BCG 99  99  99  99  98  94  86 
DTP1 97  97  97  98  98  92  86 
DTP3 95  95  95  95  94  82  69 
HepB3 95  95  95  95  94 
HepB_BD
Hib3 95  95  95  95  94 
MCV1 89  89  89  89  88  74  65 
MCV2 81  81  22 
PAB 96  94  94  94  93  89  70 
PCV3
Pol3 95  95  95  95  94  83  69 
Rota_last

Number of districts in the country 64  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 86
From 80 to 89% 14
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
IPV Yes From March 2015
MR 38 weeks; 15 years Yes < 1 year children, women at 15 years
Measles 15 Months; Yes
OPV 6, 10, 14, 38 weeks; Yes
Pneumo_conj From March 2015
TT 15 years; +1, +6 months; +1, +1 year; Yes
VitaminA 6-59 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2016  2011-2016  2011-2016  2011-2016  2011-2016  2008-2010  2008-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 64  64  70  64  64  64  64 

System performance

Total Nº districts in country number 64  64  64  64  64  64  64 
Nº districts with DTP3 coverage >=80% number 64  63  64  51  51  51  51 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  98  100  80  80  80  80 
Nº districts with measles (MCV1) coverage >=95% number 49  49  54  26  28  35  35 
% of districts with MCV1 coverage >=95% From 0 to 100% 77  77  84  41  44  55  55 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 53  33  42  37  37  40  85 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.